Cancer Tests

Myriad Genetics, Inc. (NASDAQ: MYGN) is a molecular diagnostic company engaged in the development and marketing of transformative molecular diagnostic tests. The company recently announced a new relationship with ION Solutions, a part of AmerisourceBergen Corp. (NYSE: ABC), to deliver hereditary...